22 May 2024 : Clinical Research
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pacing: A Retrospective Study of 461 Cases from 2012 to 2020
Wei-Chieh LeeDOI: 10.12659/MSM.944114
Med Sci Monit 2024; 30:e944114
Table 5 The comparison of clinical outcomes between patients without and with significant LAE after propensity score matching.
| Without significant LAE | With significant LAE | P value | |
|---|---|---|---|
| 90 | 90 | ||
| Age (years) | 70±13.7 | 70±14.7 | 0.758 |
| Male sex (%) | 47 (52.2) | 50 (55.6) | 0.765 |
| BMI (kg/m) | 23.4±5.0 | 23.0±6.8 | 0.645 |
| DM (%) | 35 (38.9) | 30 (33.3) | 0.535 |
| CAD (%) | 12 (13.3) | 14 (15.6) | 0.832 |
| Hyperlipidemia (%) | 10 (11.1) | 12 (13.3) | 0.821 |
| 7.9±5.2 | 8.1±4.6 | 0.841 | |
| LA dimension (mm) | 32.6±3.7 | 31.7±4.0 | 0.096 |
| LVEF (%) | 70.1±8.0 | 69.4±10.0 | 0.652 |
| LA dimension (mm) | 35.3±4.8 | 42.4±5.5 | <0.001 |
| LVEF (%) | 62.4±13.0 | 57.7±13.0 | 0.016 |
| Moderate to severe MR (%) | 6 (6.7) | 20 (22.2) | 0.005 |
| 5.3±2.2 | 5.5±2.3 | 0.759 | |
| ≥ | 55 (61.1) | 56 (62.2) | 1.000 |
| New-onset atrial fibrillation (%) | 15 (16.7) | 30 (33.3) | 0.015 |
| HF event (%) | 5 (5.6) | 6 (6.7) | 1.000 |
| Stroke event (%) | 3 (3.3) | 17 (18.9) | 0.001 |
| Cardiovascular mortality (%) | 1 (1.1) | 2 (2.2) | 1.000 |
| All-cause mortality (%) | 7 (7.8) | 11 (12.2) | 0.457 |
| Data are expressed as mean (standard deviation) or as number (percentage). LAE – left atrial enlargement; BMI – body mass index; DM – diabetes mellitus; CAD – coronary artery disease; F/U – follow-up; LA – left atrium; LVEF – left ventricular ejection fraction; MR – mitral regurgitation; HF – heart failure. | |||






